Bialmed sp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2001-07-17
Share capital
2,340,000.00 PLN
Activity description

Bialmed is a company that supplies medical equipment, medical supplies, and medicines to healthcare facilities such as hospitals, clinics, and pharmacies in Poland. With over 30 years of experience, they offer a wide range of products, including oncological drugs, antibiotics, disinfectants, infusion fluids, and surgical materials, totaling nearly 21,000 items. Bialmed also holds a license from the Chief Pharmaceutical Inspector for operating a pharmaceutical wholesaler.

Registered address
ul. Kazimierzowska 46/48/35, 02-546 Warszawa, Poland
Website
Email
Electronic delivery address
AE:PL-25730-37208-JTTGS-19

Financials

Revenue history (in m)

From the notes

Current income tax (CIT due)$2,698,167
Profit allocationNo decision
Receivables write-downs$15,493
Deferred tax assets$41,374
Deferred tax liability$317,402

Filing timeliness

Financial statements were filed on time, on average 62 days early. All were audited by a statutory auditor.

  • 202513/06/2026
  • 202420/05/2025
  • 202304/07/2024
  • 202213/07/2023
  • 202106/04/2022
  • 202029/04/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Industry · Wholesale of pharmaceutical goods35 / 1,136
Top 3.1%
Division · Wholesale trade151 / 20,037
Top <1%
City · Warszawa318 / 56,729
Top <1%
Voivodeship · Mazowieckie400 / 76,892
Top <1%
Country · Poland1,074 / 297,069
Top <1%

Results vs industry

Revenue
This companyUSD 203.24mMedianUSD 1.08mAverageUSD 22.54m
Net profit
This companyUSD 12.53mMedianUSD 39.26kAverageUSD 885.01k
Operating costs
This companyUSD 186.01mMedianUSD 963.92kAverageUSD 21.21m
Assets
This companyUSD 98.91mMedianUSD 610.11kAverageUSD 11.92m

Industry

Public procurement

6173 tenders recorded as contractor: 3150 national ($81,815,570) and 3023 EU ($901,488,467).

SubjectAmount
Zakup wraz z dostawą preparatów dezynfekcyjnych do pomieszczeń, powierzchni, sprzętu medycznego i skóry dla Świętokrzyskiego Centrum Onkologii w Kielcach
–
Supply of pharmaceutical products and medical devices for Powiatowe Centrum Medyczne w Grójcu sp. z o.o.
$56,418
Delivery of medicinal products (drug programmes) for Szpital Kolejowy im. dr med. Włodzimierza Roeflera at ul. Warsztatowa 1 in Pruszków.
$33,335

Trademarks

The company holds 1 active trademark registered with the Polish Patent Office. The first mark was filed in 2007.

MarkNumberClassesStatusProtected until
Bialmed Z.3204235, 10, 20, 35, 37, 39, 41, 42Protected Jan 22, 2027
MarkProtected until
Bialmed Jan 22, 2027

Authorized Representatives

Andrzej Rogiński age 61 – Management Board Member
Ryszard Rogiński age 64 – Management Board Member

Manner of representation

One-person representation.

Ownership

OwnerSharesShare valueStake
2,340$316,045.3850%
2,340$316,045.3850%

Andrzej Rogiński and Ryszard Rogiński hold a combined 100% – the ownership structure indicates family control.

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 1994-05-23.

Debt

No entries in the National Debtors Register (KRZ).

Real estate

TypeAmount
Land (incl. perpetual usufruct)
$740.3K
Buildings and premises
$8.8M

MSiG notices

Publication dateEvent
May 25, 2021Bankruptcy notice

Public aid

14 public aid cases recorded, with a total value of $2,023,781.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
$195.9K
Liquidity support for undertakings affected by the war in Ukraine
$135.9K
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$9,384

European Funds

5 projects co-financed from European Funds recorded, with total EU co-financing of $497,156.

ProjectEU co-financing
"Wzmocnienie odporności na czynniki losowe poprzez wdrożenie oprogramowania i innowacji procesowych w zakresie utrzymania ciągłości dostaw i sprzedaży w hurtowni farmaceutycznej Bialmed Sp. z o. o".
$32,567
Grant for working capital for Bialmed sp. z o.o.
$25,182
Implementation of an in-house technological and product solution for a glass blue-light filter that protects against laser radiation
$145.8K

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Hurtap S.A.
Centrala Farmaceutyczna Cefarm S.A.
Medi&More sp. z o.o.
Abbvie sp. z o.o.
Novo S.A.
Natur Produkt Zdrovit sp. z o.o.
Tramco sp. z o.o.
Lubfarm S.A.
Pelion S.A.
Przedsiębiorstwo Zaopatrzenia Farmaceutycznego Cefarm-Warszawa S.A.

Change history

DateEvent
2018-12-18Address change
2001-07-17Entered in the register

FAQ

Last updated: 2026-06-13